Abel Hall LLC
ABBV icon

Abel Hall LLC’s AbbVie ABBV Stock Holding History

Abel Hall LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.95M Buy
7,442
+64
+0.9% +$16.4K 0.35% 35
2026
Q2 		$1.86M Buy
7,378
+4,041
+121% +$869K 0.32% 43
2026
Q1 		$726K Buy
3,337
+316
+10% +$70.1K 0.15% 111
2025
Q4 		$690K Buy
3,021
+129
+4% +$29.4K 0.16% 104
2025
Q3 		$670K Buy
2,892
+9
+0.3% +$1.83K 0.27% 54
2025
Q2 		$535K Sell
2,883
-81
-3% -$15.1K 0.25% 71
2025
Q1 		$621K Buy
2,964
+359
+14% +$69.8K 0.37% 43
2024
Q4 		$463K Buy
2,605
+171
+7% +$31.4K 0.3% 53
2024
Q3 		$481K Buy
2,434
+86
+4% +$16K 0.31% 50
2024
Q2 		$403K Buy
2,348
+153
+7% +$25.3K 0.28% 57
2024
Q1 		$400K Sell
2,195
-2,047
-48% -$353K 0.3% 53
2023
Q4 		$657K Buy
+4,242
New +$618K 0.56% 28

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Abel Hall LLC's ABBV Position: Q3 2026 in Review

Abel Hall LLC increased its AbbVie (ABBV) stake by 0.87% in Q3 2026, buying an estimated $16.4K and bringing the position to 7,442 shares worth $1.95M. The position accounts for 0.35% of the portfolio, ranked #35.

Abel Hall LLC first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 1,657 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Abel Hall LLC held 7,442 shares of AbbVie worth $1.95M as of Q3 2026.
  • Abel Hall LLC bought 64 AbbVie shares in Q3 2026, an estimated $16.4K.
  • AbbVie made up 0.35% of Abel Hall LLC's portfolio in Q3 2026, its #35 holding.
  • Abel Hall LLC first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 1,657 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.